Multiple Myeloma and Amyloidosis Program

If you’ve been diagnosed with the rare diseases of multiple myeloma or amyloidosis, it’s important to be evaluated by hematology experts before beginning treatment. We can help.

Karmanos’ Multiple Myeloma and Amyloidosis Specialists

Our Multiple Myeloma and Amyloidosis Multidisciplinary Team sees between 230 and 250 new multiple myeloma patients and between 30 and 50 new amyloidosis patients each year.

The team spans many disciplines, including hematologists, medical oncologists, specialized nurse practitioners, bone marrow transplant and cellular therapy specialists, radiologists, pathologists, cardiologists, nephrologists, radiation oncologists, orthopedic surgeons, population sciences and genetics specialists, and social workers. The team is entirely focused on treating multiple myeloma, amyloidosis and related conditions. Our specialists leverage their collective expertise to create a customized treatment plan for each patient.

Our team of researchers not only has vast clinical expertise, but also years of clinical research experience. We have one of the largest myeloma bone marrow transplant programs in the country and are one of the few centers in the region offering investigational cellular therapies such as CAR-T cells to patients with multiple myeloma and amyloidosis.

In fact, Karmanos has more active clinical trials for patients with multiple myeloma and amyloidosis than any other center in the state of Michigan. In many cases, patients can participate in a trial at a Karmanos Network site near where they live. The team collaborates with basic scientists to better understand multiple myeloma and amyloidosis and to bring these new therapies to the clinic.

Evaluation & Diagnosis

Every new multiple myeloma or amyloidosis patient seen in consultation at Karmanos has his or her case reviewed in the weekly MDT meeting to facilitate a customized treatment plan and timely referral to the various subspecialists needed for optimal care. During your initial visit at a Karmanos location, a physician will review your medical records, medical history and review your x-rays and pathology slides.

Innovative, Individualized Care

Here’s what patients can expect from our Multiple Myeloma and Amyloidosis Multidisciplinary Team:

  • A passionate, caring, expert team, giving you the best chance of success.
  • A collaborative approach that considers all available treatment options, including clinical trials, for your specific type of cancer.
  • A carefully constructed treatment plan designed to achieve the best possible outcome.
  • Respectful, compassionate care that is responsive to your emotional needs and lifestyle.
  • Proactive, timely communication with you and your loved ones, and your personal physician.

Appointment Information

Request an Appointment Online Request an Appointment By Phone

The Latest From Karmanos Cancer Institute

News

Take Charge of Your Risk: What Every Woman Should Know About Ovarian Cancer

Ovarian cancer can be a difficult cancer to diagnose in the early stages because symptoms usually aren’t noticeable for women until the disease ha...

Read More

Kathleen Fedoronko Named Karmanos Cancer Institute’s Chief Nursing Officer

The Barbara Ann Karmanos Cancer Institute names Kathleen Fedoronko, MSN, RN, OCN, as the new chief nursing officer and vice president of Patient C...

Read More

IN THE NEWS – Pancreatic Cancer: Cigarette Smoke May Fuel Tumor Growth and Spread

Healthline Though it's known that smoking can cause cancer, and not just lung cancer, researchers have published a new study revealing chemicals f...

Read More
News

105.9 KISS FM | Getting a Second Opinion at Karmanos

Listen Now

WJR | Karmanos Cancer Institute Continues Its Community Education Series

Listen Now

WXYT 97.1 The Ticket | ‘Get a Mammogram’

Listen Now